IL1B and neuropathy: A previous study has demonstrated that chemotherapy-induced neuropathy is associated with the induction of proinflammation mediators (such as IL-1β and TNF-α) in the dorsal root ganglion (DRG), which may ultimately cause the initiation and maintenance of persistent neuropathy [5].